Production of scfv-conjugated affinity silk powder by transgenic silkworm technology

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Sato, Mitsuru ^a   Kojima, Katsura ^a   Sakuma, Chisato ^a   Murakami, Maria ^a   Aratani, Eriko ^a   Takenouchi, Takato ^a   Tamada, Yasushi ^a   Kitani, Hiroshi ^a  

^a NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SILK FIBROIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; WISKOTT ALDRICH SYNDROME PROTEIN; BROMIDE; FIBROIN; HYBRID PROTEIN; LITHIUM BROMIDE; LITHIUM DERIVATIVE;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; COCOON; CONTROLLED STUDY; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN PURIFICATION; SILKWORM; TRANSGENIC ORGANISM; ANIMAL; BIOSYNTHESIS; CHEMISTRY; METABOLISM; POWDER; TRANSGENIC ANIMAL;

BOMBYX MORI;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BOMBYX; BROMIDES; FIBROINS; LITHIUM COMPOUNDS; POWDERS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; SINGLE-CHAIN ANTIBODIES;

EID: 84859361274     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034632     Document Type: Article

References (28)

1. Rockwood DN, Preda RC, Yücel T, Wang X, Lovett ML, et al. (2011) Materials fabrication from Bombyx mori silk fibroin. Nat Protocols 6: 1612-1631.
2. Kim UJ, Park J, Li C, Jin HJ, Valluzzi R, et al. (2004) Structure and properties of silk hydrogels. Biomacromolecules 5: 786-792.
3. Nazarov R, Jin HJ, Kaplan DL, (2004) Porous 3-D scaffolds from regenerated silk fibroin. Biomacromolecules 5: 718-726.
4. Tamada Y, (2005) New process to form a silk fibroin porous 3-D structure. Biomacromolecules 6: 3100-3106.
5. Gotoh Y, Tsukada M, Minoura N, Imai Y, (1997) Synthesis of poly(ethylene glycol)-silk fibroin conjugates and surface interaction between L929 cells and the conjugates. Biomaterials 18: 267-271.
6. Tamada Y, (2004) Sulfation of silk fibroin by chlorosulfonic acid and the anticoagulant activity. Biomaterials 25: 377-383.
7. Murphy AR, John PS, Kaplan DL, (2008) Modification of silk fibroin using diazonium coupling chemistry and the effects on hMCS proliferation and differentiation. Biomaterials 29: 2829-2838.
8. Sofia S, McCarthy MB, Gronowicz G, Kaplan DL, (2001) Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res 54: 139-148.
9. Meinel L, Karageorgiou V, Hofmann S, Fajardo R, Snyder B, et al. (2004) Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A 71: 25-34.
10. Karageorgiou V, Meinel L, Hofmann S, Malhotra A, VollochV, et al. (2004) Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 71: 528-537.
11. Ogawa S, Tomita M, Shimizu K, Yoshizato K, (2007) Generation of a transgenic silkworm that secretes recombinant proteins in the sericin layer of cocoon: production of recombinant human serum albumin. J Biotechnol 128: 531-544.
12. Iizuka M, Ogawa S, Takeuchi A, Nakakita S, Kubo Y, et al. (2009) Production of a recombinant mouse monoclonal antibody in transgenic silkworm cocoons. FEBS J 276: 5806-5820.
13. Inoue S, Kanda T, Imamura M, Quan GX, Kojima K, et al. (2005) A fibroin secretion-deficient silkworm mutant, Nd-sD, provides an efficient system for producing recombinant proteins. Insect Biochem Mol Biol 35: 51-59.
14. Hino R, Tomita M, Yoshizato K, (2006) The generation of germline transgenic silkworms for the production of biologically active recombinant fusion proteins of fibroin and human basic fibroblast growth factor. Biomaterials 27: 5715-5724.
15. Kojima K, Kuwana Y, Sezutsu H, Kobayashi I, Uchino K, et al. (2007) A new method for the modification of fibroin heavy chain protein in the transgenic silkworm. Biosci Biotechnol Biochem 71: 2943-2951.
16. Winter G, Milstein C, (1988) Man-made antibodies. Nature 349: 293-299.
17. Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, et al. (1988) Single-chain antigen-binding proteins. Science 242: 423-426.
18. Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotny J, et al. (1988) Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci USA 85: 5879-5883.
19. Davies J, Riechmann L, (1996) Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability. Protein Eng 9: 531-537.
20. Sato M, Iwaya R, Ogihara K, Sawahata R, Kitani H, et al. (2005) Intrabodies against the EVH1 domain of Wiskott-Aldrich syndrome protein inhibit T cell receptor signaling in transgenic mice T cells. FEBS J 272: 6131-6144.
21. Derry JM, Ochs HD, Francke U, (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78: 635-644.
22. Thrasher AJ, (2002) WASp in immune-system organization and function. Nat Rev Immunol 2: 635-646.
23. Sato M, Tsuji NM, Gotoh H, Yamashita K, Hashimoto K, et al. (2001) Overexpression of the Wiskott-Aldrich syndrome protein N-terminal domain in transgenic mice inhibits T cell proliferative responses via TCR signaling without affecting cytoskeletal rearrangements. J Immunol 167: 4701-4709.
24. Gupta V, Aseh A, Rios CN, Aggarwal BB, Mathur AB, (2009) Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. Int J Nanomed 4: 115-122.
25. Mathur AB, Gupta V, (2010) Silk fibroin-derived nanoparticles for biomedical applications. Nanomedicine 5: 807-820.
26. Tamura T, Thibert C, Royer C, Kanda T, Abraham E, et al. (2000) Germline transformation of the silkworm Bombyx mori L. using a piggyBac transposon-derived vector. Nat Biotechnol 18: 81-84.
27. Ralph P, Nakoinz I, (1977) Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. J Immunol 119: 950-954.
28. Raschke WC, Baird S, Ralph P, Nakoinz I, (1978) Functional macrophage cell lines transformed by abelson leukemia virus. Cell 15: 261-267.